Every Process. Every Detail. Built Around You And Delivered With Unmatched Quality

A next-generation biomanufacturing campus in Incheon, South Korea, is designed for advanced production and process control. It emphasizes automated manufacturing, digital-first facility design, and real-time monitoring to support consistent product quality and operational efficiency. The site is built for mammalian cell-based production and large-scale, high-titer workflows, with flexible bioreactor configurations that can adapt to different development needs. A key feature is its integrated approach to analytics and mapping, which helps monitor performance continuously across the manufacturing process. The campus is described as coming online in 2026, with mechanical completion targeted for August 2026 and GMP readiness planned for early 2027. Overall, the material presents the facility as a modern, data-driven manufacturing environment focused on scalability, precision, and future-ready biopharmaceutical production.